Angiodynamics (ANGO) Total Liabilities (2011 - 2026)

Angiodynamics (ANGO) has reported Total Liabilities for 16 consecutive years, with $96.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 0.86% year-over-year to $96.3 million; the trailing twelve-month figure through May 2026 stood at $96.3 million (down 0.86% YoY), and the FY2026 full-year result was $96.3 million, down 0.86% from the prior year.
• Total Liabilities improved to $96.3 million in Q2 2026 per ANGO's latest filing, from $87.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $154.3 million in Q2 2023 and bottomed at $66.1 million in Q3 2023.
• Historically, Total Liabilities has averaged $110.0 million across 5 years, with a median of $102.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities plunged 53.94% in 2023, then soared 46.72% in 2024.
• Over 5 years, Total Liabilities stood at $150.2 million in 2022, then slumped by 34.51% to $98.4 million in 2023, then increased by 6.49% to $104.8 million in 2024, then slipped by 10.91% to $93.3 million in 2025, then climbed by 3.2% to $96.3 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $96.3 million, $87.3 million, and $93.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.